Drug interactions
Dichlorphenamide + Metformin-pioglitazone
Severity: Moderate
Dichlorphenamide and Metformin-pioglitazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dichlorphenamide is a carbonic anhydrase inhibitor that causes hyperchloremic metabolic acidosis. Metformin can cause lactic acidosis, so combining them may increase acid-base disturbance risk, especially with renal impairment.
What this interaction means in plain words
Dichlorphenamide and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dichlorphenamide belongs to Miscellaneous; Metformin-pioglitazone belongs to Endocrine.
Why it happens
Additive pharmacodynamic effects on acid-base balance: bicarbonate loss from carbonic anhydrase inhibition and metformin-associated lactate accumulation.
What to do
Monitor serum bicarbonate and renal function at baseline and periodically. Reconsider the combination if acidosis develops or persists.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-pioglitazone
Other interactions of Dichlorphenamide
Frequently asked questions
Can I take Dichlorphenamide with Metformin-pioglitazone?
MediHelp rates the interaction as moderate. Dichlorphenamide and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dichlorphenamide is a carbonic anhydrase inhibitor that causes hyperchloremic metabolic acidosis. Metformin can cause lactic acidosis, so combining them may increase acid-base disturbance risk, especially with renal impairment.
How serious is the interaction between Dichlorphenamide and Metformin-pioglitazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum bicarbonate and renal function at baseline and periodically. Reconsider the combination if acidosis develops or persists.
What other medicines interact with Metformin-pioglitazone?
MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
